<DOC>
	<DOCNO>NCT00854633</DOCNO>
	<brief_summary>This study evaluate safety , toxicity efficacy talactoferrin reduce incidence nosocomial infection prematurely-born infant .</brief_summary>
	<brief_title>Study Talactoferrin Oral Solution Nosocomial Infection Preterm Infants</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Cross Infection</mesh_term>
	<mesh_term>Lactoferrin</mesh_term>
	<criteria>Birth weight range 750 1500 gram Entry 24 hour age Informedconsent form sign parent ( ) legal guardian Able take liquid medication mouth feed tube Exclusion Criteria A major birth defect malformation syndrome Chromosomal inherit disorder Proven presence immunodeficiency Antenatal exposure illicit substance Birth asphyxia HIV congenital viral , bacterial , fungal infection Lack parental consent refusal attend neonatologist allow participation Discretion investigator The legal representative infant patient 's primary physician commit provide full , aggressive life support</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Hours</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Pre-term infant</keyword>
	<keyword>Pre-term infant 750 1500 gram</keyword>
</DOC>